How should lithium encephalopathy be managed?

Management of Lithium Encephalopathy

Immediately discontinue lithium and initiate supportive care with aggressive hydration; consider hemodialysis for severe toxicity, particularly when serum lithium levels exceed 2.5 mEq/L or when neurological symptoms are severe, regardless of serum levels.

Immediate Recognition and Discontinuation

Lithium encephalopathy represents a medical emergency requiring prompt recognition and intervention. The condition manifests with altered consciousness, confusion, ataxia, tremors, seizures, and cognitive impairment 1, 2. Critically, neurotoxicity can occur even at therapeutic serum lithium levels (0.6-1.2 mEq/L), making clinical presentation more important than laboratory values alone 3, 4, 5.

• Stop lithium immediately upon suspicion of encephalopathy, as continued exposure increases risk of permanent neurological sequelae 1, 2, 4.
• Elderly patients are particularly prone to neurotoxicity at higher dosages, requiring heightened vigilance 3.
• The diagnosis may be delayed because encephalopathy can present atypically without initial hyperlithemia 2.

Initial Supportive Management

Early symptoms of lithium toxicity can often be managed with cessation of the drug and supportive care, with treatment resumption at lower doses after 24-48 hours only in mild cases 1.

For moderate to severe toxicity:

• Perform gastric lavage if presentation is within hours of acute ingestion 1, 6.
• Correct fluid and electrolyte imbalances aggressively, as volume depletion commonly precipitates chronic lithium toxicity 7, 8.
• Maintain high-normal sodium levels, as sodium administration helps remove intracellular lithium from excitable cells 6.
• Regulate kidney function carefully, as lithium is renally excreted 1.

Role of Enhanced Elimination

Hemodialysis is the most effective and rapid method for removing lithium in severely toxic patients 1, 6.

Indications for hemodialysis include:

• Serum lithium levels >2.5 mEq/L in acute poisoning 8.
• Severe neurological symptoms (seizures, coma, severe confusion) regardless of serum level 8, 6.
• Impaired renal function preventing adequate lithium clearance 8.
• Chronic poisoning with persistent symptoms despite supportive care 8.

Alternative methods:

• Peritoneal dialysis can eliminate lithium but is less effective than hemodialysis 1, 6.
• Urea, mannitol, and aminophylline produce significant increases in lithium excretion 1.

Monitoring and Diagnostic Adjuncts

EEG is an indispensable tool for assessing lithium neurotoxicity, as it can detect abnormalities even when serum levels are therapeutic 5.

• Obtain baseline EEG when encephalopathy is suspected, as rhythm alterations may persist for months after intoxication 5.
• Monitor serum lithium levels, but recognize that plasma concentrations do not always reflect cerebrospinal fluid or neuronal lithium levels 5.
• Assess renal function (serum creatinine, creatinine clearance) as lithium toxicity is closely related to kidney function 7, 1.
• Check electrolytes, particularly sodium, as hyponatremia exacerbates toxicity 6.

Temporary Discontinuation of Interacting Medications

Discontinue potentially nephrotoxic and renally excreted drugs during acute illness that increases AKI risk 7.

Medications to temporarily stop include:

• RAAS blockers (ACE inhibitors, ARBs, aldosterone inhibitors) 7.
• Diuretics, which can precipitate volume depletion 7.
• NSAIDs, which impair renal function and should not be used with lithium 7.
• Digoxin and metformin 7.

Special Considerations for Drug Interactions

Avoid combining lithium with certain antipsychotics, particularly high-potency agents like haloperidol and risperidone, especially in patients with baseline EEG abnormalities 9.

• Lithium-neuroleptic induced encephalopathy is a rare but serious drug interaction that is reversible upon discontinuation 9.
• Concurrent use of benzodiazepines during ECT may increase seizure threshold and should be avoided when possible 10.
• There are conflicting reports regarding lithium safety with ECT; an acute brain syndrome has been reported, so discontinuation may be prudent if clinically feasible 10.

Prognosis and Long-term Sequelae

Lithium poisoning has a low mortality rate, but chronic poisoning can require prolonged hospitalization due to impaired mobility and cognition 8.

• Persistent neurological deficits, particularly cerebellar dysfunction, are described but appear uncommon in uncomplicated acute poisoning 8.
• Full recovery from dementia secondary to chronic lithium toxicity can occur even after 2 years of cognitive impairment, but only after complete cessation of lithium 4.
• Morphologic renal changes with glomerular and interstitial fibrosis have been reported in chronic lithium therapy, though the relationship to lithium is not fully established 1.

Prevention of Recurrence

Regular monitoring of GFR, electrolytes, and drug levels is mandatory for all patients taking lithium 7.

• Assess kidney function at baseline and regularly thereafter, with reevaluation needed for any progressive or sudden changes even within normal range 1.
• Educate patients and families to watch for early symptoms (tremor, confusion, ataxia) and discontinue lithium immediately if they occur 1.
• Maintain lithium levels at the lower end of the therapeutic range (0.2-0.6 mEq/L) in elderly patients to minimize neurotoxicity risk 3.